Monoacylglycerol lipase modulators
US11993601B2 · kind B2 · utility
0Cited by
28References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2023 |
| Grant date | May 28, 2024 |
| Priority date | — |
| Expiry date | Jan 27, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.